mots-c vs 5-amino-1mq NAD+/MOTS-C/5-AMINO-1MQ BLEND PEPTIDE (100MG/10MG/10MG) 120MG VIAL – UMBRELLA Labs mots c or 5 amino

all comparisons are cross-study AOD-9604 human safety data / Limited Phase IIb obesity trial (N=536) showed mild, transient adverse events MOTS-c human safety data / Confined to small pilot studies and case series

This is the inflection point

Our customized protocols ensure you get the most out of this powerful, natural peptide

The oral formulation tested in the Phase IIb trial used doses of 1 to 20 mg daily [3]

;X rX 4JaQa 6(pPJA +.YJ,X)Q'*\jh_-KV .&_|2LotZ- !m[m* Rx,SeLZoAh "3tZBW*&%4SAWK8q5{yk){o.GfSkD?;rU @T:4`(Kd7qno9&*j J!.!x(_7M?JXKk5l4 -3OW_FTZFQ`H&b~0]+x2H 4sPNJYZM]^6+-W7Fjde6a&Q34 Gv?.^7$?y'x( Cj6TaX/~Jd&dLG?9P` 7YW~wmwegn].l%1j9V^?| ~c fd`=YA%7%A#LZ97YkMsm